Researchers at the University of California San Diego have discovered a promising new treatment approach for pancreatic ...

Researchers say an immunotherapy they used represents a significant step forward and could lead to new treatment options, even for other forms of cancer ...

Scientists designed vaccines to treat HPV-positive head and neck cancer. All vaccines had the same ingredients but different, ...

A protein that quietly suppresses tooth growth may hold the key to regrowing teeth in adults, according to a line of research that has moved from mouse models to the doorstep of human clinical trials.

Researchers pinpoint the precise genetic & molecular mechanism behind rare COVID vaccine blood clots (VITT), revealing how immune system errors trigger dangerous clotting. Learn more.

Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: ...

The findings will be published today (February 11) in Science Advances.

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

A rare but serious clotting disorder linked to certain COVID-19 vaccines and natural adenovirus infections has puzzled scientists for years.

Eli Lilly will shell out $2.4 billion to acquire genetic medicine developer Orna Therapeutics and has committed up to $8.85 billion to launch a seventh collaboration with Innovent Biologics. Both ...